Periodic Field Nucleic Acid Enrichment System

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid separation techniques face challenges in resolving rare nucleic acids present at low concentrations due to stochastic amplification errors and inability to isolate low-abundance molecules without introducing sequence errors or requiring amplification steps, which limits their application in analyzing mutations and diseases.

Innovation Solution

The method employs periodic fields to enrich target nucleic acids by driving non-target nucleic acids into a waste well, creating a subsample where the target nucleic acid becomes dominant, allowing for high-fidelity detection and sequencing without amplification errors, using techniques like SCODA (Synchronous Coefficient of Drag Alteration) and zero-integrated-field electrophoresis (ZIFE) to concentrate and extract particles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If PCR amplification is used to increase the abundance of low-abundance nucleic acids, then the quantity of detectable nucleic acid increases, but sequence errors are introduced and stochastic amplification biases occur

Engineering Contradiction:
Improveabundance of nucleic acidVSAvoidsequence fidelity
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent extracts and removes non-target nucleic acids from the sample using affinity matrices and periodic field applications. By selectively binding and removing background nucleic acids, the target nucleic acid becomes enriched without requiring amplification, thus maintaining sequence fidelity while increasing detectable abundance.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent applies periodic fields (electrophoretic, acoustic, or magnetic) to dynamically manipulate the binding and release of nucleic acids to the affinity matrix. This periodic action enables selective enrichment of target sequences through repeated cycles of binding, washing, and release, achieving high purity without amplification-induced errors.

Inventive Principle:
Principle #19Periodic action

2Measurement precision

If conventional separation techniques are used to isolate low-abundance nucleic acids, then separation occurs, but resolution and fidelity are insufficient to pull enough low-abundance nucleic acids from background

Engineering Contradiction:
Improveresolution of nucleic acid separationVSAvoidamount of low-abundance nucleic acid recovered
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent performs preliminary enrichment of target nucleic acids before separation by using affinity matrices to selectively capture target sequences from the complex background. This preliminary action concentrates the low-abundance targets, enabling subsequent separation techniques to achieve both high resolution and sufficient recovery of target molecules.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces an affinity matrix as an intermediary between the sample and separation techniques. This intermediary selectively binds target nucleic acids through complementary base pairing, enabling precise separation and enrichment of low-abundance targets from background sequences with high fidelity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If all nucleic acids are amplified prior to isolation and analysis, then detection sensitivity increases, but stochastic effects cause rare nucleic acids to be missed in early rounds

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddetection consistency
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent extracts target nucleic acids from the background by using affinity matrices to selectively bind and concentrate rare sequences. By removing background interference and enriching targets before detection, the method achieves high detection sensitivity and consistency without relying on stochastic amplification processes.

Inventive Principle:
Principle #2Taking out (Extraction)

4Quantity of substance

If PCR amplification is performed to detect rare sequence variants, then signal strength increases, but error rate increases significantly affecting sequence data

Engineering Contradiction:
Improvesignal strengthVSAvoidsequence accuracy
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent replaces the biochemical amplification mechanism (PCR) with a physical enrichment mechanism using periodic fields and affinity matrices. This substitution maintains signal strength by concentrating target molecules through selective binding and field-driven manipulation, while avoiding the polymerase errors inherent in biochemical amplification.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fundamental parameter of enrichment from biochemical replication (PCR) to physical concentration (periodic field manipulation). By altering the mechanism from copying molecules to concentrating existing molecules, the method maintains sequence accuracy while achieving sufficient signal strength for detection.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the isolation and analysis of low-abundance nucleic acids with high specificity and sensitivity, reducing sample loss and error introduction, and allows for the detection of rare mutations in biological samples, such as cancer diagnostics, by enriching target nucleic acids up to 1,000,000-fold without generating new molecules.

Implementation Method 1

The method employs periodic fields to enrich target nucleic acids by driving non-target nucleic acids into a waste well

Methodology Applied
Scientific EffectElectrophoresis: Electrophoresis

Implementation Method 2

using techniques like SCODA (Synchronous Coefficient of Drag Alteration) and zero-integrated-field electrophoresis (ZIFE) to concentrate and extract particles

Methodology Applied
Scientific EffectSCODA (Synchronous Coefficient of Drag Alteration):

Implementation Method 3

using techniques like SCODA (Synchronous Coefficient of Drag Alteration) and zero-integrated-field electrophoresis (ZIFE) to concentrate and extract particles

Methodology Applied
Scientific EffectZero-integrated-field electrophoresis (ZIFE): Electrophoresis

Data Source

PatentUS10337054B2Enrichment of nucleic acid targets
Publication Date: 2019.07.02 QUANTUM SI INC
  • US10337054B2 patent drawing
  • US10337054B2 patent drawing
  • US10337054B2 patent drawing

AI summary

Methods and apparatus providing for the isolation of an unknown mutation from a sample comprising wild type nucleic acids and mutated nucleic acids through the application of time-varying driving fields and periodically varying mobility-altering fields to the sample within in an affinity matrix.